Alternatives to Erythromycin for Gastroparesis with QTc Concerns

First-Line Alternatives

Metoclopramide is the recommended first-line alternative to erythromycin for gastroparesis in patients with QTc prolongation concerns, according to the American Gastroenterological Association 1, 2
Metoclopramide can be administered orally or intravenously, making it versatile for different clinical scenarios, as noted by the American Gastroenterological Association 2
The American Diabetes Association recommends that the duration of metoclopramide therapy should not exceed 12 weeks due to risk of extrapyramidal side effects, including tardive dyskinesia 3

A combination of metoclopramide and erythromycin can be considered when single-agent therapy is insufficient, as suggested by the American Gastroenterological Association and the American Society for Parenteral and Enteral Nutrition 1, 4
This approach may be particularly useful in critically ill patients with significant feeding intolerance, according to the American Gastroenterological Association and the American Society for Parenteral and Enteral Nutrition 1

Both erythromycin and metoclopramide have been associated with QTc prolongation and predisposition to cardiac arrhythmias, as noted by the American Heart Association and the American Gastroenterological Association 1, 4
The effectiveness of erythromycin decreases to approximately one-third after 72 hours of use, according to the American Gastroenterological Association and the American Society for Parenteral and Enteral Nutrition 1, 4

Prokinetic therapy should be discontinued after three days if ineffective, as recommended by the American Gastroenterological Association and the American Society for Parenteral and Enteral Nutrition 1, 4

Dietary modifications should be implemented alongside pharmacological therapy, including small, frequent meals, low-fat, low-fiber content, and replacing solid food with liquids when symptoms are severe, as suggested by the American Gastroenterological Association and the American Diabetes Association 2, 5
In severe cases refractory to medical therapy, consider post-pyloric feeding if large gastric residual volumes persist, according to the American Gastroenterological Association and the American Society for Parenteral and Enteral Nutrition 1, 4
Gastric electrical stimulation may be considered for selected patients with symptoms refractory to medical therapies, as noted by the American Gastroenterological Association 2